ESTRO Teaching course and workshop: Current clinical issues in breast cancer |
 | P. Poortmans (The Netherlands)
| Making the case for standardising and guidelines |
| L. Boersma (The Netherlands)
| The breast, thoracic wall and boost |
| A. Biete Sola (Spain)
| The history of post-mastectomy radiotherapy: back to the future? |
| S. Darby (United Kingdom)
| Lessons from meta-analyses of clinical trials |
| B. Cutuli (France)
| Indications and target volumes for post-mastectomy radiotherapy |
| I. Kunkler (United Kingdom)
| Local control versus survival: what about toxicity? |
European Group for Breast Cancer Screening: Current issues in breast screening |
| H.J. de Koning (The Netherlands)
| Evidence for screening older women? |
| P. Skaane (Norway)
| What new evidence on digital mammography and screening? |
| F. Thibault (France)
| Overview on current data on digital tomosynthesis imaging |
| P. Taylor (United Kingdom)
| Critical appraisal of computer aided detection (CAD) |
| C. de Wolf (Switzerland)
| Making digital mammography work for screening |
European Society of Surgical Oncology: The future of sentinel lymph node biopsy |
| E.J.T. Rutgers (The Netherlands)
| Sentinel node biopsy - State of the art |
| R. Valdes-Olmos (The Netherlands)
| Sentinel lymph node today - State of the art & new nuclear medecine tools |
| S. Bianchi (Italy)
| Frozen sections - Yes or No |
| G. Viale (Italy)
| Prognostic implications of minimal lymph node involvement |
| P.J. Van Diest (The Netherlands)
| Clinical relevance of sentinel node metastases |
| O. Gentilini (Italy)
| SNB after breast surgery and in muticentric disease |
| V. Galimberti (Italy)
| SNB during pregnancy and SNB in male breast cancer |
| P. Veronesi (Italy)
| SNB in DCIS |
| C.J.H. van de Velde (The Netherlands)
| Why before and not after? |
| J. Pierga (France)
| What a medical oncologist thinks about sentinel node biopsy before, after and before and after (if possible) neo-adjuvant chemotherapy |
| A.L. Vahrmeijer (The Netherlands)
| Image guided surgery on sentinel node |
| G. Viale (Italy)
| Expert using gene search breast lymph node assay |
International Breast Ultrasound School: Breast Ultrasound - Update |
| H. Madjar (Germany)
| Update of imaging indications and US-BI-RADS |
| E. Durante (Italy)
| Evolving role of intraoperative imaging |
| R. Wilson (United Kingdom)
| Update and new developments in breast interventions |
Flims Alumni Club: Controversies in the adjuvant treatment of breast cancer |
| G. Vlastos (Switzerland)
| Micrometastases in SLN: Do they matter with respect to adjuvant therapy? |
| C. Sotiriou (Belgium)
| Treatment decisions based on genomic profile vs traditional prognostic facors: advantages, disadvantages |
| G. Atalay Basaran (Turkey)
| Taxanes as adjuvant therapy of breast cancer |
| S. Braga (Portugal)
| Are all aromatase inhibitors created equal? |
| F. Cardoso (Belgium)
| Adjuvant trastuzumab - For all Her-2 + patients? How long? |
SenoNetwork meeting: Breast units: The need for a structured network |
| M. Menke-Pluymers (The Netherlands)
| Improving quality in breast cancer care - the Dutch experience |
| M. Gnant (Austria)
| Adjuvant MUC- 1Vaccination trial |
| L. Fallowfield (United Kingdom)
| Psychological support |
| C. Wells (United Kingdom)
| EQA schemes in breast pathology |
| C. Rageth (Switzerland)
| Multidisciplinary meeting |
| M. Rosselli del Turco (Italy)
| Quality indicators |
| A. Ponti (Italy)
| Data monitoring |
Opening session: Opening session |
| J.R. Yarnold (United Kingdom)
| Research progress and priorities in breast radiotherapy |
Keynote symposium: Partnership for the fight against breast cancer |
| C. Murphy-Whyte (Ireland)
| Specialist Breast Units – The patient advocate perspective |
| L. Cataliotti (Italy)
| EUSOMA – Achieving the critical practice |
| V. Mazeau Woynar (France)
| Practice recommendations of the French National Institute of Cancer for the management of patients with breast cancer |
| L.J. van 't Veer (The Netherlands)
| Partnership in translational research - speaking each other's language |
| R.E. Coleman (United Kingdom)
| Partnership approach to clinical research in the UK |